Biorisk Management for SARS-CoV-2 Research in a Biosafety Level-3 Core Facility.

Joseph, Tessy; Phyu, Sabai; Se-Thoe, Su Yun; Chu, Justin Jang Hann

Joseph, Tessy; Phyu, Sabai; Se-Thoe, Su Yun; Chu, Justin Jang Hann.

Afiliação

Joseph T; BSL-3 Core Facility, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. medtes@nus.edu.sg.
Phyu S; Laboratory Biorisk Consultancy & Training Pte. Ltd, Singapore, Singapore.
Se-Thoe SY; European Union Chemical, Biological, Radiological and Nuclear Centres of Excellence Regional Secretariat-South East Asia/B&S Europe, Manila, Philippines.
Chu JJH; Biosafety Branch, Public Health Group, Ministry of Health, Singapore, Singapore.

Methods Mol Biol ; 2452: 441-464, 2022.

Article em En | MEDLINE | ID: mdl-35554920

Assuntos

COVID-19; SARS-CoV-2; Contenção de Riscos Biológicos; Humanos; Laboratórios; Medição de Risco

Palavras-chave

BSL-3; Biorisk management; Biosafety; Biosecurity; COVID-19; ISO 35001:2019; Risk assessment; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Methods Mol Biol Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Singapura

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google